Case Study – Pediatric Phase I/II Clinical Trial on Mucopolysaccharidosis type III (MPSIIIA)
Lab support for a global pediatric trial for the rare genetic neurodegenerative disorder, Mucopolysaccharidosis type III. Cerba Research provided safety testing, sample management, and specialized testing in our histology lab. Read the case study to discover more details.
Case Study – Pediatric Phase I/II Clinical Trial on Mucopolysaccharidosis type III (MPSIIIA)
![Cerba US Expansion Tour VF.00_04_27_19.Still010](https://cerbaresearch.com/app/uploads/2022/07/Cerba-US-Expansion-Tour-VF.00_04_27_19.Still010.jpg)
Reach out to our experts and discover how we can help you advance your research
Contact Us